The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.
作者信息
Zaman R, Jack D B, Kendall M J
出版信息
Br J Clin Pharmacol. 1981 Sep;12(3):427-9. doi: 10.1111/j.1365-2125.1981.tb01239.x.
Abstract
摘要
相似文献
1
The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.醋丁洛尔及其主要代谢物双醋洛尔在人脑脊液和唾液中的渗透情况。
Br J Clin Pharmacol. 1981 Sep;12(3):427-9. doi: 10.1111/j.1365-2125.1981.tb01239.x.
2
[Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].醋丁洛尔和双醋洛尔：它们与血浆蛋白及红细胞的结合以及随唾液的分泌
Farmakol Toksikol. 1991 Jan-Feb;54(1):53-5.
3
Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.醋丁洛尔的主要代谢产物双醋洛尔的药代动力学和生物利用度。
Eur J Clin Pharmacol. 1981 Mar;19(4):287-92. doi: 10.1007/BF00562806.
4
Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.使用一种新的立体选择性高效液相色谱法对醋丁洛尔及其代谢物双醋洛尔在人体中的处置进行的初步研究。
J Pharm Pharmacol. 1984 Apr;36(4):276-7. doi: 10.1111/j.2042-7158.1984.tb04370.x.
5
Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.肝病对醋丁洛尔和双醋洛尔药代动力学无影响：一项单剂量研究。
Biopharm Drug Dispos. 1985 Apr-Jun;6(2):131-7. doi: 10.1002/bdd.2510060204.
6
The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol.
Biopharm Drug Dispos. 1984 Jan-Mar;5(1):91-5. doi: 10.1002/bdd.2510050112.
7
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).盐酸醋丁洛尔单次口服给药（400毫克）后，以及多次口服给药期间和之后（400毫克，每日两次）在人体中的药代动力学。
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14. doi: 10.1002/bdd.2510020202.
8
Displacement of [3H]dihydroalprenolol binding from rat heart and lung by acebutolol, diacetolol and D-diacetolol.醋丁洛尔、双醋洛尔和D-双醋洛尔对大鼠心脏和肺中[3H]二氢阿普洛尔结合的置换作用。
J Pharm Pharmacol. 1983 Mar;35(3):198-9. doi: 10.1111/j.2042-7158.1983.tb04311.x.
9
To nurse when receiving acebutolol: is it dangerous for the neonate?
Eur J Clin Pharmacol. 1986;30(6):737-9. doi: 10.1007/BF00608227.
引用本文的文献
1
Improving the prediction of the brain disposition for orally administered drugs using BDDCS.利用 BDDCS 提高口服药物脑分布的预测能力。
Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. doi: 10.1016/j.addr.2011.12.008. Epub 2011 Dec 21.
2
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.醋丁洛尔。其药理学特性及在高血压、心绞痛和心律失常治疗中的疗效综述。
Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003.
3
Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.抗高血压药物的代谢产物。其临床药代动力学及治疗意义的最新综述。
Clin Pharmacokinet. 1991 Nov;21(5):331-43. doi: 10.2165/00003088-199121050-00002.
本文引用的文献
1
Blood plasma binding of acebutolol and diacetolol in man.醋丁洛尔和双醋洛尔在人体中的血浆蛋白结合情况。
Br J Clin Pharmacol. 1980 Apr;9(4):395-7. doi: 10.1111/j.1365-2125.1980.tb01067.x.
2
Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.醋丁洛尔及其主要代谢产物在血浆和尿液中的定量分析以及对其在人体处置动力学的初步观察。
Res Commun Chem Pathol Pharmacol. 1976 Sep;15(1):31-51.
3
High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.
J Chromatogr. 1977 Aug 1;138(1):183-91. doi: 10.1016/s0021-9673(00)98009-9.
4
Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.一名高血压患者脑脊液中美托洛尔的浓度
Br J Clin Pharmacol. 1977 Apr;4(2):240-1. doi: 10.1111/j.1365-2125.1977.tb00702.x.
5
CSF plasma ratios of propranolol and pindolol in man [proceedings].
Br J Clin Pharmacol. 1979 Oct;8(4):381P-382P. doi: 10.1111/j.1365-2125.1979.tb04728.x.
6
Acebutolol saliva excretion.醋丁洛尔唾液排泄
Br J Clin Pharmacol. 1979 Oct;8(4):373-5. doi: 10.1111/j.1365-2125.1979.tb04724.x.
Zotero 插件